Mounjaro Price Increase UK 2026: New Costs, Alternatives & How to Switch

In September 2025, Eli Lilly increased Mounjaro's UK list price by up to 170%, bringing the cost of the lowest dose (2.5mg) from around £146 to £189.94. The higher maintenance doses (10-15mg) now cost £300-375 per month through private clinics. Eli Lilly stated the increase was to align UK prices with European markets.

This price shock hit at the worst possible time — demand for weight loss injections in the UK has never been higher. An estimated 4.9 million UK adults have used or want to use weight loss drugs, according to UCL research published in January 2026. Many private clinics that had been offering competitive Mounjaro pricing were forced to pass on the increase to patients.

The practical impact is significant. A patient on the 15mg maintenance dose who was paying around £180/month is now looking at £350+/month — an increase of nearly £2,000 per year. For many people, this makes continued treatment financially unsustainable.

The timing also coincided with Novo Nordisk's approval of the higher-dose Wegovy 7.2mg in January 2026, which achieves comparable weight loss results to Mounjaro at potentially lower cost. This has triggered a wave of patients switching medications.

Here's the current pricing landscape for Mounjaro in the UK as of March 2026. Prices vary between pharmacies and clinics, so these represent typical ranges:

Mounjaro (Tirzepatide) Monthly Costs: - 2.5mg (starting dose): £149-190/month - 5mg: £185-240/month - 7.5mg: £220-280/month - 10mg: £260-320/month - 12.5mg: £290-350/month - 15mg (max dose): £310-375/month

Plus consultation fees (typically £50-150 for initial, £30-50 for follow-ups) and blood tests (£50-100 every 3-6 months).

Total annual cost at maintenance dose: £4,200-5,700 including monitoring.

Compare this to pre-September 2025 pricing of approximately £2,400-3,600/year — that's a £1,800-2,100 annual increase for the same medication.

Some online pharmacies like Pharmacy Planet and Simple Online Pharmacy may offer slightly lower prices through bulk purchasing, but the days of sub-£150/month Mounjaro at maintenance doses are over.

With the MHRA's January 2026 approval of Wegovy 7.2mg, the semaglutide-based alternative has become significantly more competitive. The STEP UP trial showed the new higher dose achieves 20.7% weight loss — closing the gap with Mounjaro's 22% in the SURMOUNT trials.

Wegovy (Semaglutide) Monthly Costs: - 0.25mg (starting): £135-170/month - 0.5mg: £145-180/month - 1mg: £155-195/month - 1.7mg: £170-210/month - 2.4mg (standard maintenance): £185-230/month - 7.2mg (new high dose): £220-270/month

At the standard 2.4mg maintenance dose, Wegovy is now typically £80-120/month cheaper than Mounjaro at equivalent effectiveness. Even at the new 7.2mg dose, it's often £50-100/month less.

NHS availability: Wegovy is NICE-approved and available through NHS weight management services, though waiting lists are 6-24 months depending on your area. Mounjaro is also NICE-approved but NHS rollout has been slower.

The Wegovy switch is straightforward — your prescribing doctor can transition you directly. Most patients switch at equivalent dose levels with minimal disruption.

Beyond Wegovy, several other options exist:

Saxenda (Liraglutide 3mg): The daily injection option. Cheaper than both Wegovy and Mounjaro at approximately £100-150/month, but requires daily dosing (vs weekly) and produces less weight loss (approximately 8% vs 15-22%). Available on NHS and privately.

Compounded Semaglutide: Some UK compounding pharmacies offer semaglutide at lower prices than branded Wegovy. Prices range from £80-150/month. However, quality varies significantly between compounders, and the MHRA has warned about unlicensed semaglutide products. Only use MHRA-registered compounding pharmacies.

Orforglipron (Coming Soon): Eli Lilly's oral GLP-1 agonist is in Phase 3 trials with FDA submission expected 2026. If approved, it would eliminate the need for injections entirely. UK availability would follow 12-18 months after US approval. This could be the long-term solution for patients who can wait.

NHS Route: If you haven't already, ask your GP for a referral to your local Tier 3 weight management service. NHS prescriptions are free, and eligibility criteria have been expanded. The wait is long but the cost saving over 1-2 years of private treatment is enormous.

*This article is for informational purposes only. All weight loss medications require medical supervision. Consult your GP or prescribing doctor before changing medications.*

If you've decided to switch, here's the practical process:

Step 1: Speak to your prescribing doctor. Don't switch without medical guidance. Your doctor needs to assess your current dose, response, and any side effects to plan the transition.

Step 2: Dose mapping. There's no exact dose equivalence between tirzepatide and semaglutide, but general guidance suggests: - Mounjaro 5mg → Wegovy 1mg - Mounjaro 7.5-10mg → Wegovy 1.7-2.4mg - Mounjaro 12.5-15mg → Wegovy 2.4mg or new 7.2mg

Step 3: Expect adjustment. You may experience a brief period of increased appetite during the switch as your body adjusts. The nausea profile may also change — some people tolerate one medication better than the other.

Step 4: Monitor weight. Keep weekly weigh-ins for the first 2 months after switching. Some people see a brief plateau or slight regain before the new medication reaches full effect.

Step 5: Blood work. Get standard monitoring bloods (HbA1c, lipids, liver function) 6-8 weeks after switching to ensure the new medication is working appropriately.

Many clinics now offer 'switching consultations' specifically for patients moving between GLP-1 medications, typically at a reduced fee compared to initial consultations.

*Always transition under medical supervision. Never stop or switch medications without consulting your prescribing doctor.*